April 19, 2023
1 min read
Save
FREEDOM COVID
Issue: April 2023
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Determining the safety of enoxaparin and apixaban (Eliquis, Bristol Myers Squibb/Pfizer) in patients hospitalized but not intubated with confirmed COVID-19.